The personal care giant says it will work with the FDA to ensure the integrity of the sample and the legitimacy of the tests
Johnson & Johnson (J&J) is challenging the validity of the tests that led to a recall of 33,000 baby talc products over asbestos contamination.
Tests were carried out by the FDA to identify the presence of the deadly substance in its products.
But J&J told Cosmetics Business that it is working with the FDA to . . .
This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.
Subscribe now to premium content on Cosmetics Business